ライフサイエンスコーパス: Yersinia pestis

1 formational stability of the chaperone LcrH (Yersinia pestis).

2 trophic European Black Death/bubonic plague (Yersinia pestis).

3 major surface protein of the deadly pathogen Yersinia pestis.

4 om the genome of the closely related species Yersinia pestis.

5 oding putative c-di-GMP metabolic enzymes in Yersinia pestis.

6 -encoded type III secretion system (T3SS) of Yersinia pestis.

7 tes, obesity, and infection by the bacterium Yersinia pestis.

8 rulence protein YopM of the plague bacterium Yersinia pestis.

9 were challenged with inhaled lethal doses of Yersinia pestis.

10 in human history, is caused by the bacterium Yersinia pestis.

11 ics against the potential bioterrorism agent Yersinia pestis.

12 including CDC category A/B pathogens such as Yersinia pestis.

13 nto eukaryotic cells by the plague bacterium Yersinia pestis.

14 tions, is transmitted by fleas infected with Yersinia pestis.

15 re resistant to several pathogens, including Yersinia pestis.

16 nctioning in Yersinia pseudotuberculosis and Yersinia pestis.

17 hilum, and five (2.7%) were seropositive for Yersinia pestis.

18 the phosphatase YopH, a bacterial toxin from Yersinia pestis.

19 cterial pathogens Listeria monocytogenes and Yersinia pestis.

20 ncient plague strains are basal to all known Yersinia pestis.

21 genome sequences, of which the majority are Yersinia pestis.

22 ue is a deadly respiratory disease caused by Yersinia pestis.

23 ement for Hfq in the closely related species Yersinia pestis.

24 Yersinia pestis, a Gram-negative bacterium that causes b

25 Plague is initiated by Yersinia pestis, a highly virulent bacterial pathogen.

26 Here we studied the interaction between the Yersinia pestis ABC heme importer (HmuUV) and its partne

27 The Yersinia pestis adhesin molecule Ail interacts with the

28 Yersinia pestis adopts a unique life stage in the digest

29 he consequence of a singular introduction of Yersinia pestis, after which the disease established its

30 specially potential bioterrorism agents like Yersinia pestis and Bacillus anthracis which feature on

31 -resistant Staphylococcus aureus, as well as Yersinia pestis and Bacillus anthracis, organisms of bio

32 of the same species, including 5 strains of Yersinia pestis and Bacillus anthracis.

33 the strictly conserved glycine to serine in Yersinia pestis and Escherichia coli topoisomerase I res

34 Characterization of these mutants of Yersinia pestis and Escherichia coli topoisomerase I sho

35 ly or intratracheally with the F1 antigen of Yersinia pestis and flagellin exhibited dramatic increas

36 tant of 20 nM between EGFP-labeled LcrV from Yersinia pestis and its cognate membrane-bound protein Y

37 Yersinia pestis and many other Gram-negative pathogenic

38 he cell surface of both Escherichia coli and Yersinia pestis and show that a subset of these proteins

39 o systemic infection with the KIM5 strain of Yersinia pestis and that B10.T(6R) mice become susceptib

40 tant to pigmentation locus-negative (pgm(-)) Yersinia pestis and that this phenotype maps to a 30-cen

41 s both the protective F1 capsular antigen of Yersinia pestis and the LcrV protein required for secret

42 e identification of new virulence factors in Yersinia pestis and understanding their molecular mechan

43 We report that biofilms produced by Yersinia pestis and Y. pseudotuberculosis, which bind th

44 owed differences in virulence genes found in Yersinia pestis and Yersinia pseudotuberculosis compared

45 nt of YopJ-dependent cytotoxicity induced by Yersinia pestis and Yersinia pseudotuberculosis paradoxi

46 ages were infected with a panel of different Yersinia pestis and Yersinia pseudotuberculosis strains

47 transcription factor, regulates virulence in Yersinia pestis and Yersinia pseudotuberculosis.

48 Flea-borne zoonoses such as plague (Yersinia pestis) and murine typhus (Rickettsia typhi) ca

49 flammatory response induced by other lethal (Yersinia pestis) and non-lethal (Legionella pneumophila,

50 a and Salmonella enterica serovar Typhi, and Yersinia pestis), and 3 protozoa (Leishmania spp., Plasm

51 athogenicity island, originally described in Yersinia pestis, and encodes proteins with apparent homo

52 rofloxacin resistance in Bacillus anthracis, Yersinia pestis, and Francisella tularensis.

53 een host-pathogen interactions of B. mallei, Yersinia pestis, and Salmonella enterica.

54 des genes from pathogens such as Salmonella, Yersinia pestis, and the virulent Francisella tularensis

55 ncisella tularensis, Bacillus anthracis, and Yersinia pestis are tier 1 select agents with the potent

56 plague, the most severe form of infection by Yersinia pestis, are needed, as past US Food and Drug Ad

57 The reaction mechanism of Yersinia pestis arginine decarboxylase has been investig

58 ut a potential use of the causative bacteria Yersinia pestis as an agent of biological warfare have h

59 gens, including the plague causing bacterium Yersinia pestis, avoid activating this pathway to enhanc

60 ion of either Yersinia pseudotuberculosis or Yersinia pestis bacteria express the small RNAs YSR35 or

61 t historically documented pandemic caused by Yersinia pestis began as the Justinianic Plague in 541 w

62 molecule cyclic diguanylate is essential for Yersinia pestis biofilm formation that is important for

63 itted by fleas whose feeding is blocked by a Yersinia pestis biofilm in the digestive tract.

64 and type of medium peptides associated with Yersinia pestis biomass and improve the quality of prote

65 a) in a 19th century intestinal specimen and Yersinia pestis ("Black Death" plague) in a medieval too

66 Several gram-negative pathogens, including Yersinia pestis, Burkholderia cepacia, and Acinetobacter

67 include the bacteria Francisella tularensis, Yersinia pestis, Burkholderia mallei, and Brucella speci

68 ity pathogens, including Bacillus anthracis, Yersinia pestis, Burkholderia mallei, Francisella tulare

69 Misidentification of Yersinia pestis by automated identification systems cont

70 for the type III secretion system (T3SS) in Yersinia pestis by interaction with the negative regulat

71 nto a constitutively active IpaH enzyme from Yersinia pestis by introduction of single site substitut

72 trument's response to Bacillus anthracis and Yersinia pestis by spiking the liquid sample stream with

73 es the invasiveness of the plague bacterium, Yersinia pestis, by activating plasminogen to plasmin to

74 The plague bacillus Yersinia pestis can achieve transmission by biofilm bloc

75 To test whether the protective Ags to Yersinia pestis can be orally delivered, the Y. pestis c

76 ine against plague currently consists of the Yersinia pestis capsular antigen F1 and the type 3 secre

77 The Gram-negative bacteria Yersinia pestis, causative agent of plague, is extremely

78 The 14th-18th century pandemic of Yersinia pestis caused devastating disease outbreaks in

79 Yersinia pestis causes a rapid, lethal disease referred

80 Yersinia pestis causes bubonic plague, a fulminant disea

81 Yersinia pestis causes bubonic, pneumonic, and septicemi

82 Yersinia pestis causes bubonic, pneumonic, and septicemi

83 The Gram-negative bacterium Yersinia pestis causes plague, a rapidly progressing and

84 Pulmonary infection by Yersinia pestis causes pneumonic plague, a necrotic bron

85 Pulmonary infection by Yersinia pestis causes pneumonic plague, a rapidly progr

86 The Gram-negative bacterium Yersinia pestis causes pneumonic plague, an acutely leth

87 Yersinia pestis causes primary pneumonic plague in many

88 Yersinia pestis causes the fatal respiratory disease pne

89 tructures of three active-site complexes for Yersinia pestis class IV AC (AC-IV)-two with substrate a

90 aled dose of 1.02 x 10(6) CFU of aerosolized Yersinia pestis CO92 (50% lethal dose, 6.8 x 10(4) CFU).

91 Yersinia pestis CO92 has 12 open reading frames encoding

92 Braun lipoprotein (Lpp) and MsbB attenuated Yersinia pestis CO92 in mouse and rat models of bubonic

93 sal instillation of a fully virulent strain, Yersinia pestis CO92, guinea pigs developed lethal lung

94 mples from mice experimentally infected with Yersinia pestis CO92.

95 ficant protection from a lethal challenge of Yersinia pestis CO92.

96 a multifunctional outer membrane protein of Yersinia pestis, confers cell binding, Yop delivery and

97 The pH 6 antigen (Psa) of Yersinia pestis consists of fimbriae that bind to two re

98 The pH 6 antigen (Psa) of Yersinia pestis consists of fimbriae with adhesive prope

99 Yersinia pestis continues to cause sporadic cases and ou

100 Analysis of a Yersinia pestis Delta caf1A mutant demonstrated that the

101 The second plague pandemic, caused by Yersinia pestis, devastated Europe and the nearby region

102 l infection of BALB/c mice with nonpigmented Yersinia pestis does not result in pneumonic plague.

103 ts the most severe form of disease caused by Yersinia pestis due to its ease of transmission, rapid p

104 ylase (KdoO) from Burkholderia ambifaria and Yersinia pestis, encoded by the bamb_0774 (BakdoO) and t

105 iosynthesis from Mycobacterium tuberculosis, Yersinia pestis, Escherichia coli, Vibrio cholerae, Baci

106 Yersinia pestis evolved from Y. pseudotuberculosis to be

107 In American grasslands, plague, caused by Yersinia pestis, exemplifies this quiescent-outbreak pat

108 0 degrees C), the causative agent of plague, Yersinia pestis, expresses a profile of genes distinct f

109 of mice with a recombinant fusion protein of Yersinia pestis F1 and LcrV Ags (F1-V) together with EdT

110 plant-made plague vaccine, we expressed the Yersinia pestis F1-V antigen fusion protein in tomato.

111 vaccine, we expressed our model antigen, the Yersinia pestis F1-V antigen fusion protein, with and wi

112 pture-based immunochromatographic dipsticks, Yersinia Pestis (F1) Smart II and Plague BioThreat Alert

113 ewanella oneidensis, Salmonella typhimurium, Yersinia pestis) for training and validation within and

114 s, Bacteroides fragilis, Bacillus anthracis, Yersinia pestis, Francisella tularensis, and Brucella ab

115 aromyces cerevisiae, Pseudomonas aeruginosa, Yersinia pestis, Francisella tularensis, Bacillus anthra

116 uences were designed for Bacillus anthracis, Yersinia pestis, Francisella tularensis, Brucella melite

117 acids from BT organisms (Bacillus anthracis, Yersinia pestis, Francisella tularensis, Brucella spp.,

118 -six distinct strains of Bacillus anthracis, Yersinia pestis, Francisella tularensis, Burkholderia ma

119 lytic domains from four pathogenic bacteria: Yersinia pestis, Francisella tularensis, Burkholderia ps

120 C57BL/6 mice infected with attenuated Yersinia pestis generate a dominant H2-Kb-restricted CD8

121 entional autotransporters are present in the Yersinia pestis genome, but only one, YapE, is conserved

122 Yersinia pestis has acquired a variety of complex strate

123 Yersinia pestis has caused at least three human plague p

124 ated human pathogens Salmonella enterica and Yersinia pestis has entailed functional changes in the P

125 While Yersinia pestis has multiple iron transporters, the yers

126 Plague, caused by the bacterium Yersinia pestis, has killed millions in historic pandemi

127 The causative bacterium, Yersinia pestis, has the potential to be exploited as a

128 Because Yersinia pestis HasA (HasA(yp)) presents a Gln at positi

129 utic strategies that prevent infections with Yersinia pestis have been sought for over a century.

130 ere, we report the oldest direct evidence of Yersinia pestis identified by ancient DNA in human teeth

131 tudies (influenza A in lesser snow geese and Yersinia pestis in coyotes), we argue that with careful

132 ery that regulates the entry and survival of Yersinia pestis in host macrophages is poorly understood

133 activator PhoP is important for survival of Yersinia pestis in macrophage phagosomes.

134 Growth restriction of Yersinia pestis in the absence of calcium (low-calcium r

135 ated with iron(III)-yersiniabactin import in Yersinia pestis In this study, we compared the impact of

136 responses of C57BL/6 and SEG MPs exposed to Yersinia pestis in vitro were examined.

137 Pneumonic plague resulting from Yersinia pestis induces swiftly lethal sepsis and is a m

138 ns cause host cell death upon infection, and Yersinia pestis, infamous for its role in large pandemic

139 HMBPP/IL-2 administration after inhalational Yersinia pestis infection induced marked expansion of Vg

140 A hallmark of Yersinia pestis infection is a delayed inflammatory resp

141 te to one of the most documented symptoms of Yersinia pestis infection, extensive bleeding.

142 n lymph nodes (LNs), or buboes, characterize Yersinia pestis infection, yet how they form and functio

143 ns, particularly the N terminus of YscF from Yersinia pestis, influences host immune responses.

144 Here we show that in Yersinia pestis, irp2, a gene encoding the synthetase (H

145 Yersinia pestis is a Gram-negative bacterium that is the

146 Yersinia pestis is a highly pathogenic Gram-negative org

147 Yersinia pestis is a tier 1 agent due to its contagious

148 Yersinia pestis is able to survive and replicate within

149 Yersinia pestis is an arthropod-borne bacterial pathogen

150 Yersinia pestis is an important human pathogen that is m

151 The plasminogen activator (Pla) of Yersinia pestis is an omptin family member that is very

152 Bubonic plague results when Yersinia pestis is deposited in the skin via the bite of

153 Transmission of Yersinia pestis is greatly enhanced after it forms a bac

154 The pathogenicity of the plague agent Yersinia pestis is largely due to the injection of effec

155 Yersinia pestis is perhaps the most feared infectious ag

156 This frenzied inflammatory response to Yersinia pestis is poorly understood.

157 Yersinia pestis is the causative agent of bubonic and pn

158 Yersinia pestis is the causative agent of bubonic, pneum

159 Yersinia pestis is the causative agent of plague, a dise

160 Yersinia pestis is the causative agent of plague.

161 Yersinia pestis is the etiologic agent of bubonic and pn

162 The bacteria Yersinia pestis is the etiological agent of plague and h

163 Yersinia pestis is the etiological agent of the plague.

164 The plague bacillus Yersinia pestis is unique among the pathogenic Enterobac

165 Plague (caused by the bacterium Yersinia pestis) is a zoonotic reemerging infectious dis

166 Pneumonic plague, caused by Yersinia pestis, is a rapidly progressing contagious dis

167 ds that the causative agent of this disease, Yersinia pestis, is able to survive and multiply in both

168 lague, caused by the Gram-negative bacterium Yersinia pestis, is favored by a robust early innate imm

169 YopM, a protein toxin of Yersinia pestis, is necessary for virulence in a mouse m

170 ce, also been identified in a drug-resistant Yersinia pestis isolate (IP275) from Madagascar.

171 e is the deadliest form of disease caused by Yersinia pestis Key to the progression of infection is t

172 Yersinia pestis KIM D27 mutants lacking yopR were defect

173 s from cultures of two attenuated strains of Yersinia pestis [KIM D27 (pgm-) and KIM D1 (lcr-)] grown

174 genomic DNA near IL-10 confers resistance to Yersinia pestis KIM5 and contributes to the observed res

175 Two mutant strains of Yersinia pestis KIM5+, a Deltacrp mutant and a mutant wi

176 ive TnphoA mutant library was constructed in Yersinia pestis KIM6 to identify surface proteins involv

177 ing the human pathogens Burkholderia mallei, Yersinia pestis, Klebsiella pneumoniae, Legionella longb

178 Since possible exposure to plague is via Yersinia pestis-laden aerosols that results in pneumonic

179 We report that Yersinia pestis LcrF binds to and activates transcriptio

180 d monoclonal antibodies with specificity for Yersinia pestis LcrV and F1 antigens protected mice in a

181 nst His-tagged influenza hemagglutinin 5 and Yersinia pestis LcrV antigens.

182 We find the origins of the Yersinia pestis lineage to be at least two times older t

183 Two MarA-like proteins have been found in Yersinia pestis: MarA47 and MarA48.

184 g peptides but not peptides from a disparate Yersinia pestis microbe.

185 cessfully produce disease, the causal agent (Yersinia pestis) must rapidly sense and respond to rapid

186 onment where the agent of flea-borne plague, Yersinia pestis, must replicate to produce a transmissib

187 A Yersinia pestis mutant synthesizing an adjuvant form of

188 ng disease throughout human history, such as Yersinia pestis, Mycobacterium tuberculosis, and Mycobac

189 biothreat agents such as Bacillus anthracis, Yersinia pestis, or Burkholderia pseudomallei Convention

190 We solved the crystal structures of a Yersinia pestis outer membrane transporter called FyuA a

191 Using the Yersinia pestis outer transmembrane beta-barrel Ail as a

192 high mortality, but the mechanisms by which Yersinia pestis overwhelms the lungs are largely unknown

193 through membrane remodeling is a hallmark of Yersinia pestis pathogenesis.

194 n are broadly used in many fields, including Yersinia pestis pathogenesis.

195 Attenuated Yersinia pestis pgm strains, such as KIM5, lack the side

196 Nonpigmented Yersinia pestis (pgm) strains are defective in scavengin

197 multiPhATE by annotating two newly sequenced Yersinia pestis phage genomes.

198 d release of Bacillus anthracis (anthrax) or Yersinia pestis (plague) would prompt a public health em

199 lly attenuated, pigmentation (Pgm)-deficient Yersinia pestis primes T cells that protect mice against

200 rate chain to the 2' position of lipid A, in Yersinia pestis produced bisphosphoryl hexa-acylated lip

201 Inhaled Yersinia pestis produces a severe primary pneumonia know

202 Yersinia pestis produces and secretes a toxin named pest

203 ymerization of a single protein, e.g., YscF (Yersinia pestis), PscF (Pseudomonas aeruginosa), PrgI (S

204 n model of pneumonic plague, it appears that Yersinia pestis quickly creates a localized, dominant an

205 Yersinia pestis remains endemic in Africa, Asia, and the

206 Early after inhalation, Yersinia pestis replicates to high numbers in the airway

207 Pneumonic plague, caused by inhalation of Yersinia pestis, represents a major bioterrorism threat

208 To establish a successful infection, Yersinia pestis requires the delivery of cytotoxic Yops

209 Pathogens such as Yersinia pestis resist destruction by the innate immune

210 Inhalation of the bacterium Yersinia pestis results in primary pneumonic plague.

211 The etiologic agent of bubonic plague, Yersinia pestis, senses self-produced, secreted chemical

212 hat the base pairing function of E. coli and Yersinia pestis SgrS homologs is critical for rescue fro

213 e LDC activity of a DABA DC homologue from a Yersinia pestis siderophore biosynthetic pathway.

214 In Yersinia pestis, single mutations in either yfe or feo r

215 orical interest - pre-modern bubonic plague (Yersinia pestis), smallpox (Variola virus) and cholera (

216 to approximately 100 50% effective doses of Yersinia pestis strain CO92 and necropsied at 24-h inter

217 In all Yersinia pestis strains examined, the adhesin/invasin ya

218 lague, we have sequenced the genomes of four Yersinia pestis strains isolated from the zoonotic roden

219 Yersinia pestis survives and replicates in phagosomes of

220 malian body temperature, the plague bacillus Yersinia pestis synthesizes lipopolysaccharide (LPS)-lip

221 roinflammatory responses through TLRs by the Yersinia pestis T3S needle protein, YscF, the Salmonella

222 f the enzootic maintenance of the bacterium (Yersinia pestis) that causes plague and the sporadic epi

223 In Yersinia pestis the autotransporter YapE has adhesive pr

224 Yersinia pestis (the plague bacillus) and its ancestor,

225 nse is a prominent feature of infection with Yersinia pestis, the agent of bubonic and pneumonic plag

226 Yersinia pestis, the agent of bubonic plague, evolved fr

227 r gene products are functional receptors for Yersinia pestis, the agent of plague, as shown by overex

228 Yersinia pestis, the agent of plague, is usually transmi

229 f pyrin by YopM is required for virulence of Yersinia pestis, the agent of plague.

230 Yersinia pestis, the bacterial agent of plague, forms a

231 The arthropod-borne transmission route of Yersinia pestis, the bacterial agent of plague, is a rec

232 Yersinia pestis, the bacterial agent of plague, secretes

233 Yersinia pestis, the bacterium that causes plague, is a

234 ly, there is no FDA-approved vaccine against Yersinia pestis, the causative agent of bubonic and pneu

235 Yersinia pestis, the causative agent of bubonic and pneu

236 Yersinia pestis, the causative agent of plague, autoaggr

237 Yersinia pestis, the causative agent of plague, binds ho

238 Yersinia pestis, the causative agent of plague, evades h

239 Yersinia pestis, the causative agent of plague, evolved

240 Yersinia pestis, the causative agent of plague, expresse

241 hat distinguish DNA amplicons generated from Yersinia pestis, the causative agent of plague, from the

242 Yersinia pestis, the causative agent of plague, has been

243 Yersinia pestis, the causative agent of plague, is a fac

244 Yersinia pestis, the causative agent of plague, is able

245 Yersinia pestis, the causative agent of plague, is capab

246 Yersinia pestis, the causative agent of plague, is one o

247 Yersinia pestis, the causative agent of plague, is uniqu

248 Yersinia pestis, the causative agent of plague, must sur

249 For transmission to new hosts, Yersinia pestis, the causative agent of plague, replicat

250 Yersinia pestis, the causative agent of plague, showed a

251 Yersinia pestis, the causative agent of plague, uses a t

252 Yersinia pestis, the causative agent of plague, utilizes

253 mical characterization of the AI-2 system in Yersinia pestis, the causative agent of plague.

254 -ssrA genes are required for pathogenesis of Yersinia pestis, the causative agent of plague.

255 ink between polyamines and biofilm levels in Yersinia pestis, the causative agent of plague.

256 f essential gene prediction in the bacterium Yersinia pestis, the causative agent of plague.

257 nd F1-V, a candidate recombinant antigen for Yersinia pestis, the causative agent of plague.

258 m (T3SS) is essential in the pathogenesis of Yersinia pestis, the causative agent of plague.

259 Yersinia pestis, the cause of the disease plague, forms

260 In Yersinia pestis, the deadly agent that causes plague, th

261 Yersinia pestis, the etiologic agent of plague, has only

262 Yersinia pestis, the etiologic agent of plague, is a bac

263 9 (TLR9) agonist, confers protection against Yersinia pestis, the etiologic agent of plague.

264 t the discovery and genome reconstruction of Yersinia pestis, the etiological agent of plague, in Neo

265 Yersinia pestis, the highly virulent agent of plague, is

266 in the delivery of cytotoxic Yop proteins by Yersinia pestis, the mechanism has not been defined.

267 Little is known about Zn homeostasis in Yersinia pestis, the plague bacillus.

268 lethal human disease caused by the bacterium Yersinia pestis This study demonstrated that the Y. pest

269 The ability of Yersinia pestis to forestall the mammalian innate immune

270 edium- to high-copy-number plasmid clones of Yersinia pestis topoisomerase I (YpTOP) with Asp-to-Asn

271 hionine residue with arginine in recombinant Yersinia pestis topoisomerase I (YTOP) was the only subs

272 Mutants of recombinant Yersinia pestis topoisomerase I with hydrophobic substit

273 mal system for interrogating such couplings: Yersinia pestis transmission exerts intense selective pr

274 LcrV-specific antibodies block Yersinia pestis type III injection of Yop effectors into

275 During infection, Yersinia pestis uses its F1 capsule to enhance survival

276 n, the serine/threonine kinase YopO (YpkA in Yersinia pestis), uses monomeric actin as bait to recrui

277 The causative agent of plague, Yersinia pestis, uses a type III secretion system to sel

278 ulation tests for Francisella tularensis and Yersinia pestis, using a well-established hybridization

279 The plague-causing bacterium Yersinia pestis utilizes a type III secretion system to

280 the possible role of Na(+)/H(+) antiport in Yersinia pestis virulence and found that Y. pestis strai

281 To validate these vector attributes, the Yersinia pestis virulence antigen LcrV was used to devel

282 Mutant pyrin interacts less avidly with Yersinia pestis virulence factor YopM than with wild-typ

283 es that demonstrated a role played by Lpp in Yersinia pestis virulence in mouse models of bubonic and

284 ro, His-tagged recombinant LcrV (rLcrV) from Yersinia pestis was cloned and expressed in Escherichia

285 for antimicrobial susceptibility testing of Yersinia pestis was evaluated in comparison with broth m

286 tion of the highly virulent plague bacterium Yersinia pestis was the acquisition of plasmid pPCP1, wh

287 end, immunity to LcrV, a protective Ag from Yersinia pestis, was tested in young and old baboons.

288 and genome evolution of the plague bacterium Yersinia pestis, we have sequenced the deep-rooted strai

289 atory mice are usually highly susceptible to Yersinia pestis, we recently identified a mouse strain (

290 .3, raised to the LcrV virulence factor from Yersinia pestis were characterised for their Fab affinit

291 that includes serious pathogens such as the Yersinia pestis, which causes plague, Yersinia pseudotub

292 Intentional release of Yersinia pestis will likely be propagated by aerosol exp

293 ent resistance) in the pathogenic Yersiniae (Yersinia pestis, Y. enterocolitica, and Y. pseudotubercu

294 Yersinia pestis YapV is homologous to Shigella flexneri

295 of Vibrio cholerae vibriobactin and HMWP2 of Yersinia pestis yersiniabactin assembly lines were evolv

296 investigated recognition of target genes by Yersinia pestis YopD.

297 eins, the Shigella flexneri OspF protein and Yersinia pestis YopH protein, to rewire kinase-mediated

298 e of the class IV adenylyl cyclase (AC) from Yersinia pestis (Yp) is reported at 1.9 A resolution.

299 ), as well as the causative agent of plague, Yersinia pestis (Yp).

300 HSL synthases: Burkholderia mallei BmaI1 and Yersinia pestis YspI.